LV232 40mg

DRUG2 trials

Sponsors

Vigonvita Life Sciences

Conditions

MDDMajor Depressive Disorder

Phase 1

A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

CompletedNCT06476509

Vigonvita Life SciencesMajor Depressive Disorder

Start: 2024-05-30End: 2025-05-23Updated: 2025-06-10

Phase 2

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD

RecruitingNCT06828887

Vigonvita Life SciencesMDD

Start: 2025-04-03End: 2026-12-20Target: 400Updated: 2025-04-24